AutoGenomics Unveils Test Panel For B-RAF Mutations
AutoGenomics has developed the automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with genomic and proteomic markers in the area of genetic
Telix Pharmaceuticals has officially opened a radiopharmaceutical research, manufacturing, and treatment facility in Melbourne, Australia, to expedite the delivery of new treatments for cancer.
In keeping with the streamlining focus of Oystar’s recent realignment strategy, Packaging Technologies and Aerofill Dawson will consolidate their operations into the Davenport, Iowa-based 200,000 square-foot facility. As